The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of neoadjuvant chemotherapy (NAC) on patient preferences for adjuvant treatment in muscle-invasive urothelial carcinoma (MIUC): A multi-country discrete choice experiment (DCE).
 
Edward I Broughton
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Gary D. Steinberg
Stock and Other Ownership Interests - Epivax Therapeutics; Urogen pharma
Honoraria - Aduro Biotech; AstraZeneca; Bristol-Myers Squibb; CG Oncology; enGene; Epivax Oncology; fergene; Ferring; Fidia Farmaceutici S. p. A.; FKD Therapies; Janssen Oncology; MDxHealth; Merck; Pfizer; Photocure; Roche/Genentech; Seagen; Sesen Bio; Urogen pharma
Consulting or Advisory Role - Boston Scientific; CG Oncology; Fidia Farmaceutici S. p. A.; Heat Biologics; MDxHealth; Merck; Natera; photocure; Roche/Genentech; Taris BioMedical
 
Michael Roger Harrison
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Exelixis; Fujifilm; Genentech; Janssen Oncology; Pfizer
Speakers' Bureau - Exelixis; Genentech
Research Funding - Acerta Pharma (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Exelixis (Inst); Genentech (Inst); Merck (Inst); Pfizer (Inst); Seagen (Inst)
 
Julia Braverman
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Dena H. Jaffe
Research Funding - Kantar Health (Inst)
 
Oliver Will
Other Relationship - AstraZeneca (Inst)
 
Steven S. Senglaub
Employment - Kantar Health
Stock and Other Ownership Interests - Citius Pharmaceuticals; Electrocore; Fulcrum Therapeutics; NanoVibronix; Ocugen; OpGen; Tilray; Virpax Pharmaceuticals Inc; Zomedica
Research Funding - Bristol-Myers Squibb (Inst); Janssen (Inst); Lilly (Inst)
 
Kristen King-Concialdi
No Relationships to Disclose
 
Kathleen Beusterien
Consulting or Advisory Role - Kantar Health